These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 11159714)
21. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640 [TBL] [Abstract][Full Text] [Related]
22. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Engler OB; Strasser I; Naisbitt DJ; Cerny A; Pichler WJ Toxicology; 2004 Apr; 197(1):47-56. PubMed ID: 15003333 [TBL] [Abstract][Full Text] [Related]
23. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. von Greyerz S; Zanni MP; Frutig K; Schnyder B; Burkhart C; Pichler WJ J Immunol; 1999 Jan; 162(1):595-602. PubMed ID: 9886437 [TBL] [Abstract][Full Text] [Related]
24. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600 [TBL] [Abstract][Full Text] [Related]
25. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity. Faulkner L; Gibson A; Sullivan A; Tailor A; Usui T; Alfirevic A; Pirmohamed M; Naisbitt DJ; Kevin Park B Toxicol Sci; 2016 Dec; 154(2):416-429. PubMed ID: 27637899 [TBL] [Abstract][Full Text] [Related]
26. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells. Summan M; Cribb AE Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection. Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715 [TBL] [Abstract][Full Text] [Related]
28. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055 [TBL] [Abstract][Full Text] [Related]
29. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells. Leeder JS; Nakhooda A; Spielberg SP; Dosch HM Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006 [TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole. Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572 [TBL] [Abstract][Full Text] [Related]
31. Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase. Ogese MO; Jenkins RE; Maggs JL; Meng X; Whitaker P; Peckham D; Faulkner L; Park BK; Naisbitt DJ Chem Res Toxicol; 2015 Jan; 28(1):144-54. PubMed ID: 25531135 [TBL] [Abstract][Full Text] [Related]
32. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343 [TBL] [Abstract][Full Text] [Related]
33. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Carr A; Tindall B; Penny R; Cooper DA Clin Exp Immunol; 1993 Oct; 94(1):21-5. PubMed ID: 8403509 [TBL] [Abstract][Full Text] [Related]
34. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. Schnyder B; Mauri-Hellweg D; Zanni M; Bettens F; Pichler WJ J Clin Invest; 1997 Jul; 100(1):136-41. PubMed ID: 9202065 [TBL] [Abstract][Full Text] [Related]
35. "Danger" conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells. Lavergne SN; Wang H; Callan HE; Park BK; Naisbitt DJ J Pharmacol Exp Ther; 2009 Nov; 331(2):372-81. PubMed ID: 19666748 [TBL] [Abstract][Full Text] [Related]
36. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts. Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214 [TBL] [Abstract][Full Text] [Related]